Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 24–24 | Cite as

Alemtuzumab/antithyroids

Graves' disease and hypothyroidism: case report
Case report
  • 15 Downloads

Reference

  1. Pariani N, et al. The behaviour of alemtuzumab induced graves's disease is distinctive, with a high requirement for definitive treatment, frequent fluctuations in thyroid status and development of hypothyroidism with positive anti-TSH receptor antibody levels. Endocrine Reviews 39 (Suppl. 1): no pagination abstr. OR34-6, No. 2, Apr 2018. Available from: URL: https://www.endocrine.org/meetings/endo-annual-meetings/session-listing?sessionid=2013 [abstract] - United Kingdom

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations